न्यूरोएंडोक्राइन ट्यूमर
Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors
कुठे जायचं
या ट्रायलसाठी भारतात 2 हॉस्पिटल्स रुग्ण घेत आहेत.
रजिस्ट्री सारांश (तांत्रिक)
Gastro-enteropancreatic Neuro-endocrine tumors (GEP-NETs) are rare slow-growing cancers which commonly involve the abdominal organs like liver, stomach, intestines and pancreas. Their incidence has been documented to have increased over the last decade, thus resulting in treatment options being developed to treat these cancers. These cancers spread commonly to the liver, followed by lungs, bones and other sites. Depending on the extent of disease seen on scan, treatment is planned. Patients are advised Peptide Receptor Radionuclide Therapy (PRRT), which is the current standard of treatment for…
स्पॉन्सर: टाटा मेमोरियल हॉस्पिटल
ClinicalTrials.gov वर NCT07404176
रजिस्ट्रीमध्ये शेवटचे अपडेट ११ फेब्रुवारी २०२६ · आम्ही २० ऑक्टोबर २०२६ ला वाचले